Catalogue
Learning in real time
Added:22/05/2026 09:31
Orexin receptor agonists are currently under development for the treatment of disorders of hypersomnolence. Early clinical trial results are exciting for both patients and clinicians, as they represent the potential to change the treatment landscape.
Credits awarded per Session. See individual Sessions for further details.
Credits awarded
Type
Name
Sub type
Value
Certificate awarded
Already successfully completed: This item allows re-enrollment
Recently Added Items
About this item
Orexin receptor agonists are currently under development for the treatment of disorders of hypersomnolence. Early clinical trial results are exciting for both patients and clinicians, as they represent the potential to change the treatment landscape.
Course/Activity Information
Orexin receptor agonists are currently under development for the treatment of disorders of hypersomnolence. Early clinical trial results are exciting for both patients and clinicians, as they represent the potential to change the treatment landscape. This webinar is free for members and a fee of $45.00 for non-members.
Other information
- Training Hours: 1.00
Additional Charges May Apply
Ratings and reviews
Type:
Name:
Sub type:
Value: